| Income Statement | 2025-07-31 | |||
|---|---|---|---|---|
| Revenue | 1,900 | |||
| Cost of sales | 760 | |||
| Gross margin | 1,140 | |||
| Research and development | 997,206 | |||
| Selling, general and administrative | 878,053 | |||
| Total operating expenses | 1,875,259 | |||
| Loss from operations | -1,874,119 | |||
| Interest expense | 183,688 | |||
| Other income | 2,813 | |||
| Total other income (expense), net | -180,875 | |||
| Net loss | -2,054,994 | |||
| Earnings per share, basic, total | -1.58 | |||
| Earnings per share, diluted, total | -1.58 | |||
| Weighted average number of shares outstanding, basic, total | 1,303,532 | |||
| Weighted average number of shares outstanding, diluted, total | 1,303,532 | |||
HeartSciences Inc. (HSCSW)
HeartSciences Inc. (HSCSW)